IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptD-CAOfficial filing linked

Ro Khanna disclosed SELL $AMGN

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$15K – $50K
Filed
2026-05-11
Trade date
2026-04-24
Disclosure lag
17 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 17 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
45 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Ro Khanna, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 22 lobbying filings.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 9115822 · filed 2026-05-11 · disclosed 17d after transaction

Market context

Amgen Inc.

Sector: Healthcare

Vs SPY: -0.8%

Factual flags

  • 22 lobbying filings linked to this ticker.
  • 5 nearby same-ticker disclosures in the surrounding 30-day window.
  • 366 trades filed on 2026-05-11 (batch dump)
  • Traded AMGN 4d after lobbying filing by AMGEN INC ($2,580,000)

Member trail

Ro Khanna

U.S. House · CA-17

House Committee on Armed ServicesHouse Committee on Oversight and Government ReformHouse Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party

Ticker trail

$AMGN

Amgen Inc.

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.